Skip to main content
. 2021 Jan 8;218(3):e20200839. doi: 10.1084/jem.20200839

Figure S2.

Figure S2.

Expression of SIRPα and CD47 binding of mouse and primary human NK cells. (A and B) The kinetics of Sirpα expression (A) and Cd47 binding (B) of C57BL/6 NK cells in the presence of mouse IL-2 was assessed by flow cytometry (representative histograms are shown of four independent experiments). (C and D) The kinetics of Sirpα expression (C) and Cd47 binding (D) of Sirpa/ NK cells in the presence of mouse IL-2 was assessed by flow cytometry (representative histograms are shown of four independent experiments). (E and F) The kinetics of SIRPα expression (E) and CD47 binding (F) of human primary NK cells in the presence of IL-2 was assessed by flow cytometry (representative histograms are shown of four independent experiments). (G) The expression of CD47 on five B2M/CIITA/ CD47 tg hiEC clones was assessed by flow cytometry (representative histograms of four independent experiments are shown). wt, wild-type.